文献速递围术期管理与 ERAS急腹症与外科感染

脾切除术围手术期免疫接种与外科医生责任:综述

Perioperative Immunization for Splenectomy and the Surgeon's Responsibility: A Review.
PubMed 文献 · JAMA Surg · 2020-01-01

该综述检索1990至2019年英文文献,评估脾切除后暴发性脾切除后感染(OPSI)风险与围手术期疫苗接种策略。OPSI流行病学为0.1%至8.5%,免疫接种似可降低其发生率,但接种覆盖率不理想,指南未指定负责接种的医疗资质,外科医生在计划与急诊脾切除中承担初始免疫接种的主要责任。

要点

  • 脾切除患者终身面临OPSI风险,外科医生应负责围手术期初始免疫接种。
  • 当前OPSI流行病学为0.1%至8.5%,免疫接种似可降低其发生率。
  • 多数指南建议术前术后14天内不接种,但数据提示围手术期即刻接种可能有效。

核心结论

  • 脾切除患者通过适当免疫接种可能有效预防OPSI,外科医生在计划与急诊脾切除中承担初始免疫接种的主要责任。

主要发现

  • 无脾导致先天性和适应性免疫受损,增加严重荚膜细菌感染风险。
  • 当前OPSI流行病学范围为0.1%至8.5%,但因患者基线状况和疫苗渗透率变化难以确定。
  • 尽管缺乏随机临床试验,免疫接种似可有效降低OPSI发生率。
  • 疫苗接种覆盖率仍不理想,不同机构和时间段报告的接种率差异很大。
  • 当前指南未提倡任何特定医疗资质负责疫苗处方或接种。

关键数值与推荐

  • 当前OPSI流行病学范围为0.1%至8.5%。
  • 几乎所有指南指出术前和术后14天内不接种疫苗,但多数数据提示围手术期即刻免疫接种可能有效。
  • 最佳疫苗接种时机和加强剂量需求尚未明确建立。
  • 再接种方案仍在讨论中,因推测存在疫苗驱动的低反应性。

临床怎么用

  • 外科医生应在计划性和急诊脾切除时负责实现适当的初始免疫接种。
  • 需了解脾切除疫苗接种原理以在围手术期提供适当免疫接种。
  • 尽管指南建议术前术后14天内不接种,围手术期即刻接种可能有效,外科医生可主导疫苗交付。

局限性

  • 缺乏高水平基础科学或临床证据。
  • 缺乏随机临床试验。
  • 最佳疫苗接种时机和加强剂量需求尚未明确建立。
  • 再接种方案存在争议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patients who have had splenectomy have a lifelong risk of overwhelming postsplenectomy infection (OPSI), a condition associated with high mortality rates. Surgeons must be aware of the rationale of vaccination in the case of splenectomy, to provide appropriate immunization in the perioperative time. OBSERVATIONS: English-language articles published from January 1, 1990, to December 31, 2019, were retrieved from MEDLINE/PubMed, Cochrane Library, and ClinicalTrials.gov databases. Randomized clinical trials as well as systematic reviews and observational studies were considered. Asplenia yields an impairment of both innate and adaptive immunity, thus increasing the risk of severe encapsulated bacterial infections. Current epidemiology of OPSI ranges from 0.1% to 8.5% but is hard to ascertain because of ongoing shifts in patients' baseline conditions and vaccine penetration. Despite the lack of randomized clinical trials, immunization appears to be effective in reducing OPSI incidence. Unfortunately, vaccination coverage is still suboptimal, with a great variability in vaccination rates being reported across institutions and time frames. Notably, current guidelines do not advocate any particular health care qualification responsible for vaccine prescription or administration. Given the dearth of high-level basic science or clinical evidence, the optimal vaccination timing and the need for booster doses are not yet well established. Although almost all guidelines indicate to not administer vaccines within 14 days before and after surgery, most data suggest that immunization might be effective even in the immediate perioperative time, thus placing the surgeon in a primary position for vaccine delivery. Furthermore, revaccination schedules are the target of ongoing debates, since a vaccine-driven hyporesponsiveness has been postulated. CONCLUSIONS AND RELEVANCE: In patients who have undergone splenectomy, OPSI might be effectively prevented by proper immunization. Surgeons have the primary responsibility for achieving adequate, initial immunization in the setting of both planned and urgent splenectomy.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Casciani F, Trudeau MT, Vollmer CM, et al. Perioperative Immunization for Splenectomy and the Surgeon's Responsibility: A Review. JAMA Surg. 2020. PMID: 32936229. doi:10.1001/jamasurg.2020.1463

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。